Thursday, May 24, 2012
"The source for European pharmaceutical biotechnology news..."
How the minefield that is socia media could actually prove beneficial for the world of pharma.
New concepts in risk control
Bayer’s Helmut Mothes examines the success of Lean and the development of operational excellence.
No Comments
Slim down, tone up
Realigning from the company from within to keep up with the ever-changing vitality of pharma manufacturing has been no mean feat for Novartis’ Steve Dreamer.
No Comments
Pest control
Protecting the public and pharmaceutical companies from counterfeit drugs is all in a day’s work for the MHRA’s Mick Deats.
No Comments
The genetic advantage
Allen Roses tells NGP how pharmacogenetics can help cut the size and cost of clinical trials.
No Comments
Building relationships around the globe
Wyeth’s Joan Shen examines the benefits of choosing international locations for clinical trials.
No Comments
Source: www.ngpharma.eu.com© 2012 GDS Publishing Ltd. All rights reserved.